icone plus
Contact Abonnez-vous aux actualités
Reason for request
Re-assessment of the Actual Benefit and Renewal of inclusion
Clinical Benefit
Low
The actual benefit of the proprietary medicinal product NUCTALON is low in the treatment of "severe sleep disorders in the following cases: occasional insomnia, transient insomnia. "
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
pZpfJwf4SAwjsySj
Listen
